Literature DB >> 3889356

Propranolol versus labetalol: interesting differences in efficacy.

W Flamenbaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889356      PMCID: PMC2561791     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  20 in total

1.  Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.

Authors:  J I Drayer; H J Keim; M A Weber; D B Case; J H Laragh
Journal:  Am J Med       Date:  1976-05-31       Impact factor: 4.965

2.  Labetalol and lipids.

Authors:  R J McGonigle; L Williams; M J Murphy; V Parsons
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

3.  Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients.

Authors:  M Moser; J Lunn
Journal:  Angiology       Date:  1981-08       Impact factor: 3.619

4.  Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.

Authors:  J Mehta; J N Cohn
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

Review 5.  Beta-adrenoreceptor blockade in hypertension.

Authors:  A R Lorimer; F G Dunn; J V Jones; T D Lawrie
Journal:  Am J Med       Date:  1976-05-31       Impact factor: 4.965

6.  Pharmacological basis for antihypertensive effects of intravenous labetalol.

Authors:  D A Richards; B N Prichard; A J Boakes; J Tuckman; E J Knight
Journal:  Br Heart J       Date:  1977-01

7.  Does a renal vasodilator system mediate racial differences in essential hypertension?

Authors:  S E Warren; D T O'Connor
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

8.  A study of labetalol in patients of European, West Indian and West African origin.

Authors:  K Jennings; V Parsons
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

9.  The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.

Authors:  G M Drew; A Hilditch; G P Levy
Journal:  Clin Exp Hypertens       Date:  1979       Impact factor: 1.749

10.  Direct vasodilatation by labetalol in anaesthetized dogs.

Authors:  R C Dage; C P Hsieh
Journal:  Br J Pharmacol       Date:  1980-10       Impact factor: 8.739

View more
  2 in total

1.  Behavioral efficacy of propranolol in black patients.

Authors:  C E Schorer
Journal:  J Natl Med Assoc       Date:  1987-02       Impact factor: 1.798

Review 2.  Treatment of hypertension in black patients with angiotensin-converting enzyme inhibitors.

Authors:  N B Shulman
Journal:  J Natl Med Assoc       Date:  1988-03       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.